With its share price nudging 52-week highs and the integration of recently acquired Aegerion Pharmaceuticals Inc. going well, Ireland's Amryt Pharma PLC is now finalizing plans to list on the NASDAQ stock exchange.
Amryt, which is currently listed on London's AIM market and the Irish Stock Exchange's Euronext, has filed an application with...






